Olli Kärkkäinen Selected Research

Olli Kärkkäinen Research Topics

7	Alcoholism (Alcohol Abuse) 11/2021 - 12/2013
2	Nausea 10/2020 - 10/2020
2	Tension-Type Headache (Tension Headache) 10/2020 - 10/2020
2	Inflammation (Inflammations) 11/2019 - 01/2019
1	Pre-Eclampsia (Preeclampsia) 06/2022
1	Obesity 12/2021
1	Mood Disorders (Mood Disorder) 12/2021
1	Mental Disorders (Mental Disorder) 12/2021
1	Neoplasms (Cancer) 11/2020
1	Headache (Headaches) 10/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Insulin Resistance 11/2018

2	Cysteine (L-Cysteine)FDA Link 10/2020 - 10/2020
2	VitaminsIBA 10/2020 - 10/2020
1	trimethyloxamine (trimethylamine N-oxide)IBA 06/2022
1	Biological ProductsIBA 12/2021
1	GhrelinIBA 11/2021
1	Succinic Acid (Succinate)IBA 11/2020
1	Proline (L-Proline)FDA Link 11/2020
1	Amino Acids FDA Link 11/2020
1	Vitamin B Complex (B Vitamins)IBA 11/2020
1	CreatinineIBA 11/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2020
1	Insulin (Novolin)FDA Link 11/2019
1	Rapeseed OilIBA 11/2019
1	LipidsIBA 11/2019
1	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 01/2019
1	metabotropic glutamate receptor type 1IBA 01/2019
1	Quisqualic AcidIBA 01/2019
1	oxidized low density lipoproteinIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 11/2018
1	Dehydroepiandrosterone (DHEA)IBA 01/2016
1	Naltrexone (ReVia)FDA LinkGeneric 08/2015
1	Pharmaceutical PreparationsIBA 08/2015
1	nalmefene (Revex)FDA Link 08/2015
1	metabotropic glutamate receptor 2IBA 01/2015
1	Glutamic Acid (Glutamate)FDA Link 12/2013

1	Bioreactors (Bioreactor) 01/2019
1	Therapeutics 01/2015